Business Context and Reporting Period
This Form 8-K was filed by Spherix Incorporated on June 9, 2017. The filing reports on corporate governance actions regarding a poison pill rights plan. Note: The request metadata references "Dominari Holdings Inc.," but the filing text explicitly identifies the registrant as Spherix Incorporated.
Key Financial Metrics
This filing is a Current Report regarding a material definitive agreement and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Extension of Rights Agreement: On June 9, 2017, the Company amended and restated its Rights Agreement with Transfer Online Inc.
- Expiration Date Change: The expiration date of the rights was extended from December 31, 2017, to December 31, 2020.
- Historical Context: The original Rights Agreement was entered into on January 1, 2013. The rights agent was previously changed from Equity Stock Transfer, LLC to Transfer Online Inc. in July 2016.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the standard disclosure that the description of the agreement is qualified by reference to the full text of the Amended and Restated Rights Agreement (Exhibit 4.1).
Investor Verification Checklist
- Verify the full terms of the Amended and Restated Rights Agreement filed as Exhibit 4.1 to understand the specific trigger mechanisms and redemption provisions.
- Confirm the current status of the rights plan and whether it remains in effect as of the current date.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance metrics, as this 8-K contains none.